Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Home versus hospital cervical ripening with Foley catheter or oral misoprostol for induction of labour
NL-OMON48395Phase 3Withdrawn
- Sponsor
- University Medical Center Utrecht
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of misoprostol (4 arms), sponsored by University Medical Center Utrecht. Primary endpoints: Composite neonatal safety outcome and Vaginal delivery rate. Planned start Oct 2019; status: withdrawn.
02
Drugs
misoprostol
Beyond the preview
Go deeper on NL-OMON48395.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON48395.